ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 3082 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 3082; 2) Community: the network communities that were significantly associated with the response to NSC 3082; 3) Molecule: the relationships between components within communities and NSC 3082; 4) MDR: the compounds that were significantly associated with the NSC 3082.

NSC Compound Enrichment Correlation
NSC 750335 (E)-3-(2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 0.0244718705444135 -0.16726984
NSC 756134 GSK1023156A 0.0244718705444135 0.33748754
NSC 100290 Doxypyrromycin hydrochloride 0.0244718705444139 0.38804257
NSC 123978 Sarveroside 0.0244718705444139 0.2740322
NSC 125845 Null 0.0244718705444139 0.65173922
NSC 133072 Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) 0.0244718705444139 0.67293825
NSC 13317 Null 0.0244718705444139 0.0049975722
NSC 173516 1,3,5-Triazine-2,4-diamine, 1-[4-fluoro-3-(trifluoromethyl)phenyl]-1,6-dihydro-6,6-dimethyl-, monohydrochloride 0.0244718705444139 0.85021057
NSC 176327 Ellipticine, 6-(3-aminopropyl)-9-methoxy-, dihydrochloride 0.0244718705444139 0.4920984
NSC 243022 Cinerubin A hydrochloride 0.0244718705444139 0.40766224
Total:96  Current:57    [First] [Prev] [Next] [Last]